Sandbox carlos: Difference between revisions
Jump to navigation
Jump to search
Carlos Lopez (talk | contribs) No edit summary |
Carlos Lopez (talk | contribs) No edit summary |
||
| Line 2: | Line 2: | ||
{{PBI|Cytoisospora belli}} | {{PBI|Cytoisospora belli}} | ||
:*'''Immunocompetent'''<ref></ref> | :*'''Immunocompetent'''<ref name=CDC Parasites - Cystoisosporiasis>{{cite web | title =CDC Parasites - Cystoisosporiasis| url =http://www.cdc.gov/parasites/cystoisospora/health_professionals/index.html }}</ref> | ||
::* Prefered regimen: [[Trimethoprim-sulfamethoxazole]] 160 mg/800 mg PO {{or}} IV qid for 10 days | ::* Prefered regimen: [[Trimethoprim-sulfamethoxazole]] 160 mg/800 mg PO {{or}} IV qid for 10 days | ||
Revision as of 15:46, 16 July 2015
- Cytoisospora belli
Return to Top
- Immunocompetent
- Prefered regimen: Trimethoprim-sulfamethoxazole 160 mg/800 mg PO OR IV qid for 10 days
- patients with sulfa intolerance
- Alternative regimen (1): Pyrimethamine 50-75 mg PO daily AND Leucovorin 10–25 mg PO daily
- Alternative regimen (2): Ciprofloxacin 500 mg PO BID for 7 days
- HIV
- In Patients with CD4 Count <200/mm3 (chronic treatment)
- Prefered regimen: Trimethoprim-sulfamethoxazole 160 mg/800 mg PO 3 times weekly
- Alternative regimen (1): Trimethoprim-sulfamethoxazole 320 mg/1600 mg PO 3 times weekly
- Alternative regimen (2): Pyrimethamine 25 mg PO daily AND Leucovorin 5–10 mg PO daily
- Alternative regimen (3): Ciprofloxacin 500 mg PO 3 times weekly